Literature DB >> 7698579

Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes.

M A Robin1, M Maratrat, J Loeper, A M Durand-Schneider, M Tinel, F Ballet, P Beaune, G Feldmann, D Pessayre.   

Abstract

BACKGROUND/AIMS: Autoantibodies against cytochrome P450 are found in some forms of autoimmune hepatitis. Cytochrome P450 is synthesized and mainly located in the endoplasmic reticulum but may also be expressed on the plasma membrane of hepatocytes. Vesicles migrate from the endoplasmic reticulum to the Golgi apparatus and then to the plasma membrane along microtubules. We determined the route followed by cytochrome P4502B to reach the plasma membrane.
METHODS: Rat hepatocytes were cultured for 2 hours after plating with various inhibitors of cellular trafficking. Detached, uncut, nonpermeabilized hepatocytes were then exposed to a monoclonal antibody specific for cytochrome P4502B and studied by flow cytometry and confocal microscopy.
RESULTS: The plasma membrane expression of cytochrome P4502B was markedly decreased after 2 hours of culture with cycloheximide (an inhibitor of protein synthesis), caffeine at 20 degrees C (conditions that decrease vesicular transport from the endoplasmic reticulum to the Golgi apparatus), brefeldin A (which redistributes Golgi components back to the endoplasmic reticulum), monensin (an inhibitor of Golgi functions), and colchicine, vinblastine, or nocodazole (three microtubule inhibitors).
CONCLUSIONS: Part of cytochrome P4502B follows a microtubule-dependent vesicular route from the endoplasmic reticulum to the plasma membrane in cultured rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698579     DOI: 10.1016/0016-5085(95)90210-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

3.  Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

Authors:  L Muratori; M Parola; A Ripalti; G Robino; P Muratori; G Bellomo; R Carini; M Lenzi; M P Landini; E Albano; F B Bianchi
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 4.  Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis.

Authors:  K H Meyer zum Büschenfelde; H P Dienes
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

Review 5.  Drug-induced immunotoxicity.

Authors:  P M Dansette; E Bonierbale; C Minoletti; P H Beaune; D Pessayre; D Mansuy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.441

Review 6.  Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.

Authors:  P Obermayer-Straub; M P Manns
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

7.  Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

Authors:  M A Robin; M Maratrat; M Le Roy; F P Le Breton; E Bonierbale; P Dansette; F Ballet; D Mansuy; D Pessayre
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Pheromone anosmia in a scarab beetle induced by in vivo inhibition of a pheromone-degrading enzyme.

Authors:  Martine Maïbèche-Coisne; Alexander A Nikonov; Yuko Ishida; Emmanuelle Jacquin-Joly; Walter S Leal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

9.  In vitro study of lovastatin interactions with amiodarone and with carbon tetrachloride in isolated rat hepatocytes.

Authors:  A-Z Krasteva; M-K Mitcheva; M-S Kondeva-Burdina; V-A Descatoire
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.